Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

UTIs and Estrogen: the Overlooked Link

By Ashley Winter, MD; Rachel Rubin, MD; and Howie Mell, MD, MPH | on February 16, 2022 | 2 Comments
Features
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

There are no data—none—showing that local vaginal estrogen causes cancer, cardiovascular problems, stroke, dementia, or any other issues. In fact, two decades of research show just the opposite. Even studies in women who have gynecological cancers show no issues using local vaginal estrogens.10,11 We prescribe and encourage this therapy in our patients with breast cancer or a family history of breast cancer as well as those who are worried about breast cancer.

You Might Also Like
  • Health Issues To Consider Among Transgender Patients
  • Support for Shorter-Course Antibiotics in Older Men with Urinary Tract Infections
  • U.S. CDC Finds More Clotting Cases After J&J Vaccine, Sees Causal Link
Explore This Issue
ACEP Now: Vol 41 – No 02 – February 2022

Let’s Look at a Quick Example

At one point during gestation, pregnant patients will have systemic estrogen levels of roughly 3,000 pg/mL. At the same time, if we measured the estrogen level in the biological fathers of these pregnancies, we would expect levels of roughly 25 pg/mL. Menopausal women’s systemic estrogen levels are less than 5 pg/mL, and on vaginal estrogen, they remain at roughly 5 pg/mL. Our point? Local vaginal estrogen does not impact the amount of estrogen in your bloodstream. How is it going to cause tumor growth, dementia, or blood clots? It’s not, and it doesn’t.12 A birth control pill has different risks than an IUD, which has very different risks from local vaginal estrogen. All hormones are not the same.

Perhaps now you are sold on this diagnosis and its treatment, but how do you do it because standard emergency medicine training does not include this particular therapy? Starting local vaginal hormone therapy is easy and should be started in the emergency department. There are some key points to remember when explaining the therapy to patients:

  1. There are lots of options out there, including inserts, gels, and rings.
  2. If cost and insurance coverage are issues, generic estradiol 10-mcg inserts are typically $40/month with a cash price and GoodRx coupon. Advise one vaginal insert daily for two weeks, then twice weekly indefinitely.
  3. It may take as long as two to three months to see maximal benefit (remember the tissue must heal, which takes time).
  4. It will only keep working if you keep using the therapy. For a woman who needs vaginal estrogen therapy, asking when the therapy should stop is like asking, “When can I stop brushing my teeth?” or “When can I stop wearing my seat belt?” Never. The answer is never.

The next time you encounter a postmenopausal women with recurrent UTIs, think about GSM, an essential and easily treatable diagnosis for emergency physicians who care for older women.


Dr. Ashley Winter (@AshleyGWinter) and Dr. Rachel Rubin (@drrachelrubin), two renowned urologists who focus on sexual medicine, joined forces with emergency physician Dr. Howie Mell (@drhowiemell) to compose this article after a productive conversation sparked on Twitter about a better approach to patients presenting with recurrent urinary tract infections.

Pages: 1 2 3 | Single Page

Topics: Antibioticsgenitourinary syndrome of menopause (GSM)hormone therapyUrinary Tract Infectionvaginitis

Related

  • What’s in The Drug Pipeline These Days?

    August 4, 2025 - 0 Comment
  • Settling the Cefepime versus Piperacillin-Tazobactam Debate

    November 7, 2024 - 1 Comment
  • Diagnosing Lower Urinary Tract Infections

    May 10, 2024 - 0 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

2 Responses to “UTIs and Estrogen: the Overlooked Link”

  1. February 21, 2022

    Jon Spangler Reply

    As a 70-year-old man, I have known many women who are post-menopausal and “of a certain age,” including my wife. Urinary tract infections seem to be a common affliction and the authors’ recommendations seem to be simple, effective, and safe.

    I hope this good news can safely and accurately be publicized and the benefits of long-term localized estrogen therapy made widely available.

    Indirectly, this can improve the lives of many men, too, when our sisters, mothers, friends, partners, and spouses are healthier and happier!

    How can we make sure that the word gets out on this good news?

  2. July 8, 2025

    Clare Reply

    I agree I have had a hysterectomy and went into menopause very quickly. I started with lack of collagen and tendonopathy caused by a quick drop in oestrogen which caused inflammation and my body to attack soft tissue. I then had atrophy below and started having UTI infections which came back repeatedly I am now trying vaginal oestrogen now I know the problem. All women especially if they have had a hysterectomy should be offered this earlier as UTI infections are life threatening and very scary when they repeatedly come back. Hope this information helps others.

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603